CPS
  • Home

Sign in or register to track your progress, save, and view your completed history.

Breast Cancer, Cervical Cancer, Esophageal Cancer, Gastric Cancer, Head & Neck Cancer, Lung Cancer, Urothelial Cancer

Implementation of PD-L1 Testing in the New Era of an Everchanging Immuno-oncology Landscape

    clockimg 74m
  • Webinar
  • Foundational
 saveimgSave unsaveimgUnsave

The Precision Pathology Insights webinar series brings you expert PD-L1 evaluation insights. Since 2017, the series has provided key perspectives from industry leaders to help sharpen your Combined Positive Score (CPS) expertise and PD-L1 evaluation skills. This webinar is presented by Dr. Carol Cheung from University of Toronto. Recorded on 24 September 2020.​

 

 

Dr. Carol Cheung delivers expert insights on the topic of “Implementation of PD-L1 Testing in the New Era of an Everchanging Immuno-oncology Landscape“:​

  • Novel complexities of today’s PD-L1 testing environment​
  • Validation and verification criteria for PD-L1 testing​
  • Considerations and tradeoffs for interchangeability of PD-L1 testing​
  • A real-world example of successful implementation and optimization of PD-L1 workflow​
Carol Cheung​, MD, PhD, JD, FRCPC

Carol Cheung​, MD, PhD, JD, FRCPC

Pathologist, University Health Network, University of Toronto, Canada​

Related Training

This website discusses general principles for CDx scoring and is intended for educational purposes only. Not all cancer indications mentioned are approved worldwide. Please consult local Instructions for Use for more information.​D0113744_1.00